Recent News

By Region: North America

Biosecurity champions recognised with AHA awards

(Beef Central) A veterinary epidemiologist who is playing a key role in Australia’s foot and mouth (FMD) emergency response planning and a NSW farmer who has established a biosecurity conscious cattle and equestrian centre have been recognised with awards from Animal Health Australia. Dr Sam Hamilton, a member of the Commonwealth Department of Agriculture, Forestry  Read More »

The threat of bio-terrorism

(Alarabiya) This is not an article about a revolutionary weapon, which if it lands in the wrong hands would kill only a few people. This is a much bigger issue that must be taken seriously. In an unstable world where technology is advancing rapidly in both military and medical fields, it is important that the  Read More »

Misinformation undermines understanding of scientific development, says ANBio

(Sys-Con Media) The National Biosafety Association (ANBio), the most important Brazilian organization on biosafety, warned about the dissemination of research developed without appropriate scientific methodology, without statistical significance and elaborated in a rather biased way. Dr. Leila Oda, president of the organization, states that ideological positions can influence quite negatively the understanding of reputable scientific  Read More »

Novel Coronavirus infection in the United Kingdom

(World Health Organization) On 22 September 2012, the United Kingdom (UK) informed WHO of a case of acute respiratory syndrome with renal failure with travel history to the Kingdom of Saudi Arabia (KSA) and Qatar. The case is a previously healthy, 49 year old male Qatari national that presented with symptoms on 3 September 2012  Read More »

Sarepta Therapeutics’ Ebola and Marburg drugs granted ‘Fast Track’ status

(Examiner) Cambridge, Massachusetts biotechnology company, Sarepta Therapeutics, Inc. announced Tuesday that the U.S. Food and Drug Administration (FDA) have granted Fast Track status for the development of two of its drug candidates. According to a Sept. 18 Sarepta press release, the infectious disease drug candidates, AVI-7288 and AVI-7537, for the treatment of Marburg virus and  Read More »